Teva Pharmaceuticals announced it would sell a “lower-cost” alternative to Syprine, an old drug that costs more than $21,000. But the new generic version costs nearly as much.
Published: February 23, 2018 at 01:00AM
from NYT Health https://ift.tt/2sOiwTA